Literature DB >> 27316494

Eustachian valve - Masquerading ASD rim.

Monish S Raut1, Arun Maheshwari2, Sumir Dubey3, Ganesh Shivnani3, Aman Makhija4, Arun Mohanty4.   

Abstract

Entities:  

Keywords:  Atrial septal defect; Echocardiography; Eustachian valve

Mesh:

Year:  2016        PMID: 27316494      PMCID: PMC4911437          DOI: 10.1016/j.ihj.2016.03.026

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


× No keyword cloud information.
A 34-year-old male presented with shortness of breath on moderate exertion since 2 months. Electrocardiogram was suggestive of right axis deviation and right bundle branch block. Transthoracic echocardiographic evaluation reported atrial septal defect (ASD) with left to right shunt. Qp:Qs was 2:1. Size of the defect reported was 21 mm. The patient was referred to our center for ASD device closure. Before undergoing device closure procedure, transesophageal echocardiography (TEE) was performed. Bicaval TEE view showed ASD of 21 mm with adequate superior and inferior rims (Fig. 1, Fig. 2). However midesophageal 4-chamber view showed defect size of 24 mm with inadequate inferior rim. Midesophageal bicaval view was again performed with slight rotation of the probe and it revealed large eustachian valve (Fig. 3). Free end of eustachian valve was initially confused with superior rim of ASD. The same view with probe manipulation depicted true superior rim of ASD and inadequate aortic rim. Rim size less than 5 mm in anterior, inferior, or superior aspects of the ASD can potentially cause complications of device closure procedure.1, 2, 3 Considering deficient ASD rim, device closure procedure was abandoned and the patient was scheduled for surgical defect closure. Comprehensive transesophageal echocardiographic examination is essential as large eustachian valve can be easily mistaken for atrial septal rim as in the present case. ASD was surgically closed with dacron patch in this patient. Postoperative course of the patient remained stable.
Fig. 1

Midesophageal bicaval view showing eustachian valve (marked by yellow arrow) mistaken as superior rim of ASD.

Fig. 2

Midesophageal modified bicaval view showing eustachian valve (marked by yellow arrow) mistaken as superior rim of ASD.

Fig. 3

Midesophageal aortic valve short axis view showing eustachian valve and true superior ASD rim and deficient aortic rim.

Conflicts of interest

The authors have none to declare.
  3 in total

1.  Echocardiographic characteristics of secundum-type atrial septal defects in adult patients: implications for percutaneous closure using Amplatzer septal occluders.

Authors:  Katja Prokselj; Mirta Kozelj; Vesna Zadnik; Tomaz Podnar
Journal:  J Am Soc Echocardiogr       Date:  2004-11       Impact factor: 5.251

2.  ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease).

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  Circulation       Date:  2008-11-07       Impact factor: 29.690

3.  Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients.

Authors:  Gianfranco Butera; Enrico Romagnoli; Mario Carminati; Massimo Chessa; Luciane Piazza; Diana Negura; Alessandro Giamberti; Raul Abella; Giuseppe Pomè; Claudia Condoluci; Alessandro Frigiola
Journal:  Am Heart J       Date:  2008-07-30       Impact factor: 4.749

  3 in total
  1 in total

1.  Eustachian valve-Masquerading ASD rim.

Authors:  K M Krishnamoorthy; Arun Gopalakrishnan; Deepa S Kumar; S S Sivasankaran
Journal:  Indian Heart J       Date:  2017-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.